The Oncology Institute, Inc. (TOIIW)
USD 0.03
(2.96%)
USD 0.03
(2.96%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -77.01 Million USD | 16.62% |
| 2022 | -72 Million USD | -57.02% |
| 2021 | -45.85 Million USD | -459.52% |
| 2020 | -8.19 Million USD | -211.07% |
| 2019 | -2.63 Million USD | -155.01% |
| 2018 | 4.78 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -16.36 Million USD | 8.95% |
| 2024 Q1 | -17.97 Million USD | -17.57% |
| 2023 Q4 | -15.28 Million USD | -9.77% |
| 2023 Q1 | -16 Million USD | -5.72% |
| 2023 FY | -60.03 Million USD | 16.62% |
| 2023 Q2 | -14.93 Million USD | 6.64% |
| 2023 Q3 | -13.92 Million USD | 6.78% |
| 2022 Q4 | -15.13 Million USD | 24.69% |
| 2022 FY | -72 Million USD | -57.02% |
| 2022 Q3 | -20.09 Million USD | -9.8% |
| 2022 Q2 | -18.3 Million USD | 0.9% |
| 2022 Q1 | -18.47 Million USD | 54.76% |
| 2021 Q1 | -1.75 Million USD | 77.28% |
| 2021 Q4 | -40.83 Million USD | -1792.95% |
| 2021 Q3 | -2.15 Million USD | -93.07% |
| 2021 Q2 | -1.11 Million USD | 36.27% |
| 2021 FY | -45.85 Million USD | -459.52% |
| 2020 Q2 | 139.71 Thousand USD | 105.29% |
| 2020 Q1 | -2.64 Million USD | 0.0% |
| 2020 FY | -8.19 Million USD | -211.07% |
| 2020 Q4 | -7.71 Million USD | -3787.09% |
| 2020 Q3 | -198.48 Thousand USD | -242.06% |
| 2019 FY | -2.63 Million USD | -155.01% |
| 2018 FY | 4.78 Million USD | 0.0% |
| 2018 Q4 | -1.16 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 115.203% |
| Addus HomeCare Corporation | 90.95 Million USD | 184.676% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 912.169% |
| Amedisys, Inc. | 156.39 Million USD | 149.246% |
| American Oncology Network, Inc. | -49.15 Million USD | -56.687% |
| Astrana Health, Inc. | 84.61 Million USD | 191.024% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 1054.138% |
| IMAC Holdings, Inc. | -6.37 Million USD | -1108.029% |
| biote Corp. | 28.65 Million USD | 368.758% |
| Cryo-Cell International, Inc. | -12.3 Million USD | -525.957% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 168.331% |
| COMPASS Pathways plc | -136.91 Million USD | 43.749% |
| DocGo Inc. | 15.05 Million USD | 611.578% |
| The Ensign Group, Inc. | 255.36 Million USD | 130.16% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 223.509% |
| InnovAge Holding Corp. | -23.18 Million USD | -232.261% |
| Assure Holdings Corp. | -20.08 Million USD | -283.518% |
| The Joint Corp. | -2.07 Million USD | -3615.136% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 59.279% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | -390.444% |
| ModivCare Inc. | -139.94 Million USD | 44.966% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 182425.647% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | -800.462% |
| Option Care Health, Inc. | 314.59 Million USD | 124.482% |
| P3 Health Partners Inc. | -167.86 Million USD | 54.118% |
| P3 Health Partners Inc. | -167.86 Million USD | 54.118% |
| The Pennant Group, Inc. | 25.16 Million USD | 406.003% |
| Surgery Partners, Inc. | 328 Million USD | 123.481% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -2567.199% |
| Talkspace, Inc. | -23.2 Million USD | -231.845% |
| Talkspace, Inc. | -23.2 Million USD | -231.845% |
| The Oncology Institute, Inc. | -77.01 Million USD | -0.0% |